Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial
Titel:
Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial
Auteur:
Guo, J. Carvajal, R.D. Dummer, R. Hauschild, A. Daud, A. Bastian, B.C. Markovic, S.N. Queirolo, P. Arance, A. Berking, C. Camargo, V. Herchenhorn, D. Petrella, T.M. Schadendorf, D. Sharfman, W. Testori, A. Novick, S. Hertle, S. Nourry, C. Chen, Q. Hodi, F.S.